GO
Loading...

The Week on Wall Street

CNBC.com
Thursday, 5 Apr 2007 | 5:51 PM ET

Stocks finished higher during a holiday-shortened week, helped by a spate of merger announcements and an easing of geopolitical tensions after Iran released 15 British sailors.

Gains were limited, however, by mixed economic data and uncertainty ahead of first-quarter earnings season. Tech stocks were a bright spot, while the housing-sensitive financial sector was among the biggest downside weekly movers.

For the week, the Nasdaq gained 2.2%, the Dow rose 1.7% and the S&P 500 climbed 1.5%. The major markets have now almost fully recovered from the late-February stock selloff.

On Monday, stocks managed to squeak by with gains at the close as a flurry of mergers helped investors shrug off weaker manufacturing data.

Concerns about the housing market abated on Tuesday following a positive surprise in the latest home sales and a sharp pullback in crude oil prices, sending the Dow up 128 points and a new five-week high. Oil declined as a resolution between Britain and Iran, appeared imminent.

On Wednesday, Iran made it official, calling the release of 15 British sailors a "gift" for England. Tech stocks were in focus after Wall Street analysts expressed optimism for software giant

Wall Street ended the week early on Thursday as stocks rose for the sixth day following news from the auto industry. Billionaire financier Kirk Kerkorian's investment firm Tracinda offered DaimlerChrysler $4.5 billion for the German automaker's Chrysler division. DaimlerChrysler and General Motors both closed Thursday with solid gains.

Market Wrap
The second quarter earnings parade is about to begin and the markets seem to be chugging along just fine, with Emanuel Balarie, Wisdom Financial sr. market strategist; Horacio Valeiras, Allianz NACM International Fund portfolio manager and CNBC's Melissa Francis

Monday

The second quarter earnings parade is about to begin and the markets seem to be chugging along just fine, with Emanuel Balarie, Wisdom Financial sr. market strategist; Horacio Valeiras, Allianz NACM International Fund portfolio manager and CNBC's Melissa Francis.

Market Wrap
The markets have a big rally today as oil and subprime fears seem to have faded away, with A.C. Moore, Dunvegan Associates chief investment strategist; Ron Insana, CNBC sr. analyst and CNBC's Melissa Francis

Tuesday

The markets rallied big as subprime worries diminished following better-than-expected housing data. A.C. Moore, chief investment strategist at Dunvegan Associates; CNBC's Melissa Francis and Ron Insana, senior analyst.

Market Wrap
A volatile trading day includes a lot of buying in the market and a look ahead to Friday's employment report, with Donald Coxe, BMO Financial Group Global portfolio strategist; Brian Stine, Allegiant Asset Management investment strategist and CNBC's Melissa Francis

Wednesday

A volatile trading day includes a lot of buying in the market and a look ahead to Friday's employment report, with Donald Coxe, BMO Financial Group Global portfolio strategist; Brian Stine, Allegiant Asset Management investment strategist and CNBC's Melissa Francis.

The Week that Was
A look ahead to the next week's business and financial news, with CNBC's Bill Griffeth

Thursday

Stocks closed modestly higher but ended up for the sixth session in a row ahead of Friday's jobs data.

  Price   Change %Change
MSFT
---
SNDK
---
MU
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Mad Money's Jim Cramer discusses Micron Technology and how the company gained control over inventory issues. The bears expect the company's history to repeat itself, but Cramer says this time, it feels different.

  • In this excerpt from a live CNBC interview, Warren Buffett explains why it's extremely unusual for a company's directors to vote against executive compensation plans.

  • Mad Money host Jim Cramer says shareholder activism works for every shareholder, and offers his take on the Valeant/Bill Ackman bid to acquire Allergan. The market is better off for these efforts, he says.